Neurology and psychopharmacology.
D000698:Analgesia; D003863:Depression / Q000139:chemically induced; D006801:Humans; D006816:Huntington Disease / Q000188:drug therapy; D007046:Hysteria / Q000139:chemically induced; D008094:Lithium / Q000627:therapeutic use; D009069:Movement Disorders / Q000188:drug therapy*; D010300:Parkinson Disease / Q000188:drug therapy / Q000378:metabolism; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010640:Phenothiazines / Q000009:adverse effects / Q000627:therapeutic use; D011600:Psychopharmacology; D011618:Psychotic Disorders / Q000378:metabolism; D011619:Psychotropic Drugs / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D013892:Thioxanthenes / Q000009:adverse effects / Q000627:therapeutic use
D010640:Phenothiazines; D011619:Psychotropic Drugs; D013892:Thioxanthenes; D008094:Lithium